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Abstract
Snail plays an important role in the epithelial-to-mesenchymal
transition during development and in tumor progression. Induction
of Snail expression coincides with drastic morphological changes
in cultured epithelial cells. Recently, a new role for Snail in tumor
recurrence has been inferred from a reversible HER-2/neu-induced
breast cancer mouse model. Comparative transcriptome analysis
of human primary breast cancers suggests that elevated Snail
expression is correlated with decreased relapse-free survival.
Further characterization of Snail as master regulator in this process
might enhance our understanding of the molecular and cellular
changes during and after breast tumor recurrence.
Early detection of breast cancer is crucial for the survival of
breast cancer patients. However, for unknown reasons
almost a quarter of patients with breast cancer without overt
lymph node metastases suffer metastatic relapse within 10
years post-surgery. To increase survival, it is necessary to
improve treatment and prevent recurrence. This requires a
more thorough understanding of the molecular basis of
breast cancer recurrence.
In Cancer Cell, Moody and colleagues [1] described the
spontaneous up-regulation of the transcription factor Snail in
recurrent breast tumors in a transgenic mouse model. In this
model, tetracycline-inducible HER2/neu expression is targeted
to the mammary gland by the mammary specific expression of
the reverse TET transactivator (rtTA). Withdrawal of tetra-
cycline inactivates HER2/neu expression, resulting in
remarkable regression of breast tumors. Surprisingly, most
recurrences were accompanied by an epithelial-to-mesen-
chymal transition (EMT), a form of phenotypic and functional
plasticity that occurs spontaneously during tumor progres-
sion. Once the tumor achieves the dedifferentiated stage of
single-cell dissemination, metastasis accelerates and prog-
nosis worsens [2]. Microarray analysis of these particular
tumor recurrences showed strong up-regulation of the trans-
cription factor Snail, a key player in EMT. Primary breast
cancer cells transduced with Snail and grafted sub-
cutaneously in mice showed rapid recurrence upon
inactivation of the HER2/neu pathway, which indicates that
Snail contributes functionally to tumor recurrence in vivo.
Snail family members encode zinc-finger transcription factors
that are organized similarly: they are composed of a highly
conserved carboxy-terminal region that binds E-box consen-
sus sequences in target promoters, and a much more
divergent amino-terminal region. The vertebrate Snail genes
code for both Snail and Slug proteins [3]. The finding that
Snail can repress the expression of the invasion-suppressor
protein E-cadherin was important evidence linking Snail to
cancer [4,5]. E-cadherin is a Ca2+-dependent cell-cell
adhesion protein that performs important functions during
embryogenesis and during morphogenesis of adult tissues,
as it is necessary in the formation of cell polarity in epithelial
cell differentiation [6]. In a variety of human carcinoma types,
loss of E-cadherin is associated with dedifferentiation,
invasion and metastasis [7].
Snail appears to act as a master regulator, repressing the
epithelial phenotype by affecting the transcription of many
genes implicated in the specific structure of the epithelial cell
[8]. During development of Drosophila, Snail has an intimate
relationship with Twist, a basic helix-loop-helix (bHLH) factor.
Twist functions as a positive regulator of mesoderm-specific
genes, and Snail acts as repressor of ectodermal genes, and
together they define the borders of the mesoderm and the
surrounding tissue [9]. In human mammary tumor
progression, this cooperation might be supplanted by
independence, with Twist linked to metastasis [10] and Snail
to recurrence [1].
This finding demands a plausible explanation of how tumor
recurrence acquires this apparent Snail expression. Putatively,
the dramatic tumor regression that follows inactivation of the
oncogene neu would result in a temporary situation in which
the primary tumor site becomes highly activated, as in post-
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EMT = epithelial-to-mesenchymal transition.
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surgical wounds. It has been shown that wound-drainage
fluid taken after breast cancer surgery stimulated proliferation
of different breast cancer cell lines [11]. Consistent with this
finding, it is generally accepted that EMT can be induced by a
variety of growth factors, such as epidermal growth factor,
fibroblast growth factor, hepatocyte growth factor and
transforming growth factor-β; furthermore, it has been
reported that the expression of Snail family members is
downstream from these pathways [12] (Figure 1).
Going one step further, one might speculate that Snail has a
role in allowing the self-maintenance of the early pool of
recurrent cells. It has been shown that Snail can induce
DeltaEF1 [13], another transcriptional repressor of
E-cadherin regulating epithelial plasticity in breast cancer
cells [14]. Besides its role as repressor of the epithelial
phenotype, Snail acts as a survival factor. In fact, up-
regulation of Snail could be a rapidly induced epigenetic
variation aimed at genetically inhibiting cell death. Indeed,
expression of Snail seems to protect cells from caspase-
mediated programmed cell death elicited by serum depletion
or by signals downstream of therapeutic agents, tumor
necrosis factor-α and DNA damage [15,16]. In this context it
is worth mentioning that the highly homologous Slug seems
to be a target gene of p53 and acts as an antagonist of
PUMA (p53-upregulated modulator of apoptosis) [17]. Snail
can repress KLF4 [8], a tumor suppressor that can repress
p53 levels and simultaneously induce p21CIP1 [18]. Pointing
in the same direction are the data from conditional
hypomorphic Snail expression in mice, in which resistance to
radiation and to formation of spontaneous epithelial and
mesenchymal tumors is increased [19].
By reanalyzing existent microarray expression data sets,
Chodosh and colleagues [1] also show that Snail expression
could have predictive value for recurrence in subsets of
primary human breast cancers. Although the value of gene
signatures predictive of breast cancer recurrence is heavily
debated, it should also be noted that the original research
papers never suggested that Snail is of key importance for
the identified metastasis signatures. Furthermore, in their
analysis, Snail expression could not be associated with two
important prognostic markers: tumor size and lymph node
status. This is unexpected, because the role of Snail as a
repressor of the epithelial differentiated state argues that it
would promote disease progression. An interesting question
is whether these local mesenchymal outgrowths result in a
more pronounced metastatic phenotype in the mouse, which
would be representative of recurrence in humans.
The importance of these new insights, in our opinion, should
be viewed with care, as interpreting the expression levels of
Snail mRNA is cumbersome: elevated cellular expression of
Snail could be due to stromal contamination, and low
expression could become diluted in the whole of a tumor
extract. Furthermore, expression at the mRNA level does not
necessarily mean nuclear functional activity, because Snail
could be localized in the cytoplasm. The need for highly
Figure 1
Schematic of local cancer recurrence in a reversible HER2/neu mouse model. Inactivation of HER2/neu expression results in the regression of
breast tumors. Both epigenetic selection and a cocktail of extracellular signals can establish a population of Snail expressing cells allowing
epithelial-to-mesenchymal transition and survival, eventually leading to mesenchymal recurrences. BMP, bone morphogenetic protein; EGF(-R),
epidermal growth factor (-receptor); FGF(-R), fibroblast growth factor (-receptor); MMP, matrix metalloproteinase; PTC, patched; SCF, stem cell
factor; Shh, sonic hedgehog; Smo, smoothened; TGF-β(-R), transforming growth factor beta (-receptor); WNT, member of the Wnt family of
peptide ligands.
Page 3 of 3
(page number not for citation purposes)
efficient antibodies that allow evaluation of the protein
expression status are essential for understanding the interest-
ing connection between HER-2/neu, Snail and EMT as a real
functional marker for breast cancer recurrence, which could
then generate new ways for rational therapeutic intervention.
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